**Author details**

Nagaraju Vallepu1 \*, Saikiran Velpula1 , Bharath Kumar Dasari1 , Manish Kumar Thimmaraju<sup>2</sup> , Sridhar Babu Gummadi3 , Neeraja Yelugam1 and Supraja Jannu1

1 Department of Pharmacy Practice, Balaji Institute of Pharmaceutical Sciences, Warangal, Telangana, India

2 Department of Pharmaceutical Analysis, Balaji Institute of Pharmaceutical Sciences, Warangal, Telangana, India

3 Sri Shivani College of Pharmacy, Warangal, Telangana, India

\*Address all correspondence to: vallepunagaraju99@gmail.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**63**

*Causes and Pathophysiology of Nephrotic Syndrome in Childhood*

of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney International.

[10] Nash MA et al. The nephrotic syndrome. In: Edelmann CMJ, editor. *Pediatric Kidney Disease*. Boston: Little,

[11] Srivastava T, Simon SD, Alon US. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatric Nephrology. 1999;**13**(1):13-18

[12] Ravani P, Rossi R, Bonanni A, et al. Rituximab in children with steroiddependent nephrotic syndrome: A multicenter, open-label, noninferiority, randomized controlled trial. Journal of the American Society of Nephrology.

Brown, and Company; 1992

2004;**66**(2):571-579

2015;**26**:2259-2266

2015;**35**:83-89

[13] Coulthard MG. Oedema in kwashiorkor is caused by hypoalbuminaemia. Paediatrics and International Child Health.

[14] Hogg RJ et al. Evaluation and management of proteinuria and nephrotic syndrome in children: Recommendations from a pediatric nephrology panel established at the National Kidney Foundation

risk, assessment, detection, and elimination (PARADE). Pediatrics.

2000;**105**(6):1242-1249

or focal glomerulosclerosis.

1982;**29**(4):875-894

conference on proteinuria, albuminuria,

[15] McEnery PT, Strife CF. Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation,

Pediatric Clinics of North America.

[16] Bonilla-Felix M et al. Changing patterns in the histopathology of

*DOI: http://dx.doi.org/10.5772/intechopen.86825*

[1] Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza FC, Mezzano SA, et al. Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney International Supplements. 2012;**2**:139-274. DOI: 10.1038/

[2] Arneil GC. The nephrotic syndrome. Pediatric Clinics of North America.

[3] Arneil GC, Lam CN. Long-term assessment of steroid therapy in childhood nephrosis. Lancet.

[4] Lenkkeri U et al. Structure of the gene for congenital nephritic syndrome of the Finnish type (NPHS1) and characterization of mutations. American Journal of Human Genetics.

[5] Hinkes B et al. Genetic causes of nephrotic syndrome in the first year of life. American Pediatric Nephrology

[6] Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet.

Lafayette RA, et al. Complete remission in the nephrotic syndrome study network. Clinical Journal of the American Society of Nephrology.

[8] Ruf RG et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. Journal of the American Society of Nephrology.

[9] Weber S et al. NPHS2 mutation analysis shows genetic heterogeneity

**References**

kisup.2012.9

1971;**18**(2):547-559

1966;**2**(7468):819-821

1999;**64**(1):51-61

Meeting. Marburg; 2006

2003;**362**(9384):629-639

[7] Gipson DS, Troost JP,

2016;**11**:81-89

2004;**15**(3):722-732

*Causes and Pathophysiology of Nephrotic Syndrome in Childhood DOI: http://dx.doi.org/10.5772/intechopen.86825*
